Develops and commercializes cannabinoid-based therapeutics.
Industry: Health Care
First Day Return: +0.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/19/2013 |
Offer Price | $8.90 |
Price Range $10.79 - $10.79 | |
Offer Shares (mm) | 3.5 |
Deal Size ($mm) | $31 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/01/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $31 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Wilshire, United Kingdom |
Founded | 1998 |
Employees at IPO | 182 |
Website www.gwpharm.com |